Ori Biotech

Jason Foster, CEO

Oct. 10 | 12:00pm | Rentschler ATMP Ballroom

London, UK


Ori Biotech is revolutionizing cell and gene therapy manufacturing by pioneering flexible process discovery with seamless transition to scalable commercialization. Ori has developed a proprietary, full stack manufacturing platform that closes, automates, standardizes and digitizes CGT manufacturing, allowing research and therapeutics teams the flexibility to both develop and bring their products to market at commercial scale. The promise of the innovative Ori platform is to fully automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining innovation across three pillars: biology, proprietary hardware engineering, and digital-first approach.


By using this website you agree to accept our Privacy Policy and Terms & Conditions